Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial

Background: The clinical benefits of cytochrome P450 (CYP) 2C19 genotype-guided antiplatelet therapy in Asians remain unclear. In this study, we aimed to investigate the clinical outcomes of pharmacogenomic antiplatelet therapy in Chinese patients. Methods: Patients with acute coronary syndrome plan...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiujin, Zhang, Yunnan, Zhang, Yi, Zhang, Ru, Lin, Baidi, Han, Jialun, Li, Wenzheng, Fang, Zhenwei, Yan, Jialin, Wang, Yifan, Zheng, Ze, Lv, Yuan, Lin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242578/
https://www.ncbi.nlm.nih.gov/pubmed/34222372
http://dx.doi.org/10.3389/fcvm.2021.676954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242578/
https://www.ncbi.nlm.nih.gov/pubmed/34222372
http://dx.doi.org/10.3389/fcvm.2021.676954

Ejemplares similares